The Efficacy of Sub-Anesthesia S-Ketamine on Postoperative Depressive Symptoms in Patients Undergoing Abdominal Tumor Resection: A Randomized Controlled Trial
- PMID: 40831094
- DOI: 10.1002/pon.70265
The Efficacy of Sub-Anesthesia S-Ketamine on Postoperative Depressive Symptoms in Patients Undergoing Abdominal Tumor Resection: A Randomized Controlled Trial
Abstract
Background: Cancer patients undergoing major surgery often have perioperative depression symptoms, and are associated with worsened outcomes.
Aims: We aimed to evaluate the efficacy of S-ketamine in alleviating depressive symptoms after abdominal Tumor surgery.
Methods: A prospective, double-blind, placebo-controlled randomized trial was conducted, enrolling 230 patients with newly screened mild-to-severe depressive symptoms scheduled for abdominal tumor resection. Participants were randomly assigned to receive either 0.4 mg/kg of S-ketamine or normal saline. The primary outcome was the difference in treatment response rates, which defined as a 50% decrease from baseline in Patient Health Questionnaire-9 (PHQ-9) on postoperative day (POD) 1. Secondary outcomes included global quality of recovery (QoR-15) scores and adverse events. Group-based trajectory modeling was used to identify the potential trajectories of depression severity over the postoperative 7-day and the risk factors were also analyzed.
Results: On POD 1, the S-ketamine group demonstrated a slightly higher treatment response (odds ratio [OR], 1.4 [95% confidence interval (CI), 0.8 to 2.6], p = 0.017), a reduction in PHQ-9 scores (MD -1.0 [95% CI, -2.0 to 0]; p = 0.002) and higher QoR-15 scores (MD -2.2 [95% CI: -4.3 to -0.7]; p = 0.043). However, the treatment responses, PHQ-9 scores and QoR-15 scores were similar on POD 3 and 7. Adverse events were comparable between the two groups. Additionally, logistic regression did not indicate significant associations between treatment allocation.
Conclusions: This study found the effects of sub-anesthesia S-ketamine on depressive symptoms in this patient population postoperatively were limited. The long-term efficacy needs to be explored.
Trial registration: Chinese Clinical Trial Registry Identifier: ChiCTR 2200065298.
Keywords: S‐ketamine; abdominal tumor resection; postoperative depressive symptoms; quality of recovery.
© 2025 John Wiley & Sons Ltd.
References
-
- A. J. Mitchell, M. Chan, H. Bhatti, et al., “Prevalence of Depression, Anxiety, and Adjustment Disorder in Oncological, Haematological, and Palliative‐Care Settings: A Meta‐Analysis of 94 Interview‐Based Studies,” Lancet Oncology 12, no. 2 (2011): 160–174, https://doi.org/10.1016/s1470‐2045(11)70002‐x.
-
- S. M. Gold, O. Kohler‐Forsberg, R. Moss‐Morris, et al., “Comorbid Depression in Medical Diseases,” Nature Reviews Disease Primers 6, no. 1 (2020): 69, https://doi.org/10.1038/s41572‐020‐0200‐2.
-
- M. Orri, E. Boleslawski, J. M. Regimbeau, et al., “Influence of Depression on Recovery After Major Noncardiac Surgery: A Prospective Cohort Study,” Annals of Surgery 262, no. 5 (2015): 882–889: discussion 89‐90, https://doi.org/10.1097/sla.0000000000001448.
-
- W. Lu, H. Pikhart, A. Peasey, R. Kubinova, A. Pitman, and M. Bobak, “Risk of Depressive Symptoms Before and After the First Hospitalisation for Cancer: Evidence From a 16‐Year Cohort Study in the Czech Republic,” Journal of Affective Disorders 276 (2020): 76–83, https://doi.org/10.1016/j.jad.2020.06.070.
-
- D. Chen, H. Yang, L. Yang, et al., “Preoperative Psychological Symptoms and Chronic Postsurgical Pain: Analysis of the Prospective China Surgery and Anaesthesia Cohort Study,” British Journal of Anaesthesia 132, no. 2 (2024): 359–371, https://doi.org/10.1016/j.bja.2023.10.015.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
